0
Skip to Content
Nordic Migraine Symposium 2026
Home
Agenda
Venue & Accommodation
NMS 2025
NMS 2024
NMS 2023
NMS 2022
NMS 2021
NMS 2020
NMS 2019
Contact
REGISTER NOW
Nordic Migraine Symposium 2026
Home
Agenda
Venue & Accommodation
NMS 2025
NMS 2024
NMS 2023
NMS 2022
NMS 2021
NMS 2020
NMS 2019
Contact
REGISTER NOW
Home
Agenda
Venue & Accommodation
Folder: Previous years
Back
NMS 2025
NMS 2024
NMS 2023
NMS 2022
NMS 2021
NMS 2020
NMS 2019
Contact
REGISTER NOW

Combination therapy and switching

Session 4: Pathophysiological Aspects

Anne Christine Poole

General practitioner and headache specialist at Oslo Headache Centre, Norway

Download presentation

Previous

Safety and tolerability, wearing-off

You Might Also Like

Related Embedded Video Item Thumbnail Pathophysiological Aspects
Related Embedded Video Item Thumbnail Intelligent digital technology in migraine management: examples from NTNU, Norway
Related Embedded Video Item Thumbnail Targeting ion channels
Related Embedded Video Item Thumbnail Discrepancy between the recommendations and reimbursement regulations of the anti-CGRPs in the Nordics
Related Embedded Video Item Thumbnail Safety and tolerability, wearing-off

Privacy policy

Teva Privacy Notice |Teva Pharmaceuticals

Legal Notes | Teva Pharmaceuticals

Accessibility Statement

Teva code of conduct

Norway, Finland, Denmark: AJO-DK-NP-00128